Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bio-Path Holdings, Inc. (BPTH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.0500-0.3000 (-6.90%)
At close: 04:00PM EST
4.1900 +0.14 (+3.46%)
After hours: 07:55PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.3500
Open4.3800
Bid3.9400 x 1000
Ask4.1400 x 900
Day's Range3.9400 - 4.3899
52 Week Range3.3500 - 24.3400
Volume136,884
Avg. Volume91,652
Market Cap28.189M
Beta (5Y Monthly)1.92
PE Ratio (TTM)N/A
EPS (TTM)-2.2980
Earnings DateAug 12, 2021 - Aug 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.50
  • GlobeNewswire

    Bio-Path Holdings Reports Third Quarter 2021 Financial Results

    Conference Call to be Held Today at 8:30 A.M. ETHOUSTON, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the third quarter ended September 30, 2021 and provided an update on recent corporate developments. “The clinical and regulatory advances made during the third

  • GlobeNewswire

    Bio-Path Holdings to Announce Third Quarter 2021 Financial Results on November 12, 2021

    HOUSTON, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Friday, November 12, 2021 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2021 and to provide a business overview. To access the live conf

  • GlobeNewswire

    Bio-Path Holdings to Present Clinical Data at the 63rd Annual American Society of Hematology Annual Meeting

    HOUSTON, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced an upcoming poster presentation at the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition, taking place from December 11-14, 2021 in Atlanta, GA. In addition, ASH abstracts will appear in the November supplemental is

Advertisement
Advertisement